Effects of eicosapentaenoic acid treatment on epicardial and abdominal visceral adipose tissue volumes in patients with coronary artery disease

Journal of Atherosclerosis and Thrombosis

Volumn 21, Issue 10, 2014, Pages 1031-1043

  Sato, Takao ^a   Kameyama, Tomoki ^a   Ohori, Takashi ^b   Matsuki, Akira ^b   Inoue, Hiroshi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b Itoigawa General Hospital   (Japan)

Author keywords

Anti atherosclerosis; Atherosclerosis; Multislice computed tomography

Indexed keywords

ICOSAPENTAENOIC ACID;

AGED; BLOOD; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY DISEASE; DRUG EFFECTS; FEMALE; HUMAN; INTRAABDOMINAL FAT; MALE; MIDDLE AGED; PATHOLOGY; PERICARDIUM;

AGED; CORONARY ARTERY DISEASE; EICOSAPENTAENOIC ACID; FEMALE; HUMANS; INTRA-ABDOMINAL FAT; MALE; MIDDLE AGED; PERICARDIUM; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84908156237     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.23390     Document Type: Article

References (53)

1. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW Jr: Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med, 1999; 341: 1097-1105
2. Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, Ballard-Barbash R, Hollenbeck A, Leitzmann MF: Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med, 2006; 355: 763-778
3. Matsuzawa Y, Funahashi T, Nakamura T: Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances. Ann N Y Acad Sci, 1999; 892: 146-154
4. Hirata Y, Tabata M, Kurobe H, Motoki T, Akaike M, Nishio C, Higashida M, Mikasa H, Nakaya Y, Takanashi S, Igarashi T, Kitagawa T, Sata M: Coronary atherosclerosis is associated with macrophage polarization in epicardial adipose tissue. J Am Coll Cardiol, 2011; 58: 248-255
5. Shimabukuro M, Hirata Y, Tabata M, Dagvasumberel M, Sato H, Kurobe H, Fukuda D, Soeki T, Kitagawa T, Takanashi S, Sata M: Epicardial adipose tissue volume and adipocytokine imbalance are strongly linked to human coronary atherosclerosis. Arterioscler Thromb Vasc Biol, 2013; 33: 1077-1084
6. Hirata Y, Kurobe H, Akaike M, Chikugo F, Hori T, Bando Y, Nishio C, Higashida M, Nakaya Y, Kitagawa T, Sata M: Enhanced inflammation in epicardial fat in patients with coronary artery disease. Int Heart J, 2011; 52: 139-142
7. Itoh M, Suganami T, Satoh N, Tanimoto-Koyama K, Yuan X, Tanaka M, Kawano H, Yano T, Aoe S, Takeya M, Shimatsu A, Kuzuya H, Kamei Y, Ogawa Y: Increased adiponectin secretion by highly purified eicosapentaenoic acid in rodent models of obesity and human obese subjects. Arterioscler Thromb Vasc Biol, 2000; 27: 1918-1925
8. Clément K, Basdevant A, Dutour A: Weight of pericardial fat on coronaropathy. Arterioscler Thromb Vasc Biol, 2009; 29: 615-616
9. Jeong JW, Jeong MH, Yun KH, Oh SK, Park EM, Kim YK, Rhee SJ, Lee EM, Lee J, Yoo NJ, Kim NH, Park JC: Echocardiographic epicardial fat thickness and coronary artery disease. Circ J, 2007; 71: 536-539
10. Baker AR, Silva NF, Quinn DW, Harte AL, Pagano D, Bonser RS, Kumar S, McTernan PG: Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc Diabetol, 2006 13; 5: 1
11. Covington MB: Omega-3 fatty acids. Am Fam Physician, 2004; 70: 133-140
12. Batetta B, Griinari M, Carta G, Murru E, Ligresti A, Cordeddu L, Giordano E, Sanna F, Bisogno T, Uda S, Collu M, Bruheim I, Di Marzo V, Banni S: Endocannabinoids may mediate the ability of (n-3) fatty acids to reduce ectopic fat and inflammatory mediators in obese Zucker rats. J Nutr, 2009; 139: 1495-1501
13. Lavie CJ, Milani RV, Mehra MR, Ventura HO: Omega-3 polyunsaturated fatty acids and cardiovascular diseases. J Am Coll Cardiol, 2009; 54: 585-594
14. Inoue K, Kishida K, Hirata A, Funahashi T, Shimomura I: Low serum eicosapentaenoic acid/arachidonic acid ratio in male subjects with visceral obesity. Nutr Metab (Lond), 2013; 10: 25-32
15. Matsuzawa Y: Metabolic syndrome--definition and diagnostic criteria in Japan. J Atheroscler Throm, 2005; 12: 301
16. Tani S, Nagao K, Matsumoto M, Hirayama A: Highly purified eicosapentaenoic acid may increase low-density lipoprotein particle size by improving triglyceride metabolism in patients with hypertriglyceridemia. Circ J, 2013; in press
17. Itakura H, Yokoyama M, Matsuzaki M, Saito Y, Origasa H, Ishikawa Y, Oikawa S, Sasaki J, Hishida H, Kita T, Kitabatake A, Nakaya N, Sakata T, Shimada K, Shirato K, Matsuzawa Y: JELIS Investigators: Relationships between Pg12Pg12 1042 Sato et al. plasma fatty acid composition and coronary artery disease. J Atheroscler Thromb, 2011; 18: 99-107
18. Kamiya T, Takano A, Matsuzuka Y, Kusaba N, Ikeguchi M, Takagaki K, Kondo K: Consumption of Pueraria flower extract reduces body mass index via a decrease in the visceral fat area in obese humans. Biosci Biotechnol Biochem, 2012; 76: 1511-1517
19. Dicker D, Herskovitz P, Katz M, Atar E, Bachar GN: Computed tomography study of the effect of orlistat on visceral adipose tissue volume in obese subjects. Isr Med Assoc J, 2010; 12: 199-202
20. Ito R, Satoh-Asahara N, Yamakage H, Sasaki Y, Odori S, Kono S, Wada H, Suganami T, Ogawa Y, Hasegawa K, Shimatsu A: An Increase in the EPA/AA Ratio is Associated with Improved Arterial Stiffness in Obese Patients with Dyslipidemia. J Atheroscler Thromb, 2013; 22: 000-000
21. Dagvasumberel M, Shimabukuro M, Nishiuchi T, Ueno J, Takao S, Fukuda D, Hirata Y, Kurobe H, Soeki T, Iwase T, Kusunose K, Niki T, Yamaguchi K, Taketani Y, Yagi S, Tomita N, Yamada H, Wakatsuki T, Harada M, Kitagawa T, Sata M: Gender disparities in the association between epicardial adipose tissue volume and coronary atherosclerosis: a 3-dimensional cardiac computed tomography imaging study in Japanese subjects. Cardiovasc Diabetol, 2012; 11: 106
22. Sacks HS, Fain JN: Human epicardial adipose tissue: a review. Am Heart J, 2007; 153: 907-917
23. Mazurek T, Zhang L, Zalewski A, Mannion JD, Diehl JT, Arafat H, Sarov-Blat L, O’Brien S, Keiper EA, Johnson AG, Martin J, Goldstein BJ, Shi Y: Human epicardial adipose tissue is a source of inflammatory mediators. Circulation, 2003; 108: 2460-2466
24. Matsuzawa Y, Shimomura I, Nakamura T, Keno Y, Kotani K, Tokunaga K: Pathophysiology and pathogenesis of visceral fat obesity. Obes Res, 1995; l 2: 187S-194S
25. Fujimoto WY, Abbate SL, Kahn SE, Hokanson JE, Brunzell JD: The visceral adiposity syndrome in JapaneseAmerican men. Obes Res, 1994; 2: 364-371
26. McLaughlin T, Lamendola C, Liu A, Abbasi F: Preferential fat deposition in subcutaneous versus visceral depots is associated with insulin sensitivity. J Clin Endocrinol Metab, 2011; 96: E1756-E1760
27. Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y, Oikawa S, Sasaki J, Hishida H, Itakura H, Kita T, Kitabatake A, Nakaya N, Sakata T, Shimada K, Shirato K; Japan EPA lipid intervention study (JELIS) Investigators: Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet, 2007; 369: 1090-1098
28. Flachs P, Rossmeisl M, Bryhn M, Kopecky J: Cellular and molecular effects of n-3 polyunsaturated fatty acids on adipose tissue biology and metabolism. Clin Sci (Lond), 2009; 116: 1-16
29. Neschen S, Morino K, Rossbacher JC, Pongratz RL, Cline GW, Sono S, Gillum M, Shulman GI: Fish oil regulates adiponectin secretion by a peroxisome proliferator-activated receptor-gamma-dependent mechanism in mice. Diabetes, 2006; 55: 924-928
30. Matsumoto M, Sata M, Fukuda D, Tanaka K, Soma M, Hirata Y, Nagai R: Orally administered eicosapentaenoic acid reduces and stabilizes atherosclerotic lesions in ApoEdeficient mice. Atherosclerosis, 2008; 197: 524-533
31. Schwab JM, Chiang N, Arita M, Serhan CN: Resolvin E1 and protectin D1 activate inflammationresolution programmes. Nature, 2007; 447: 869-874
32. Satoh-Asahara N, Shimatsu A, Sasaki Y, Nakaoka H, Himeno A, Tochiya M, Kono S, Takaya T, Ono K, Wada H, Suganami T, Hasegawa K, Ogawa Y: Highly purified eicosapentaenoic acid increases interleukin-10 levels of peripheral blood monocytes in obese patients with dyslipidemia. Diabetes Care, 2012; 35: 2631-2639
33. Lumeng CN, Bodzin JL, Saltiel AR: Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest, 2007; 117: 175-184
34. Suganami T, Nishida J, Ogawa Y: A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha. Arterioscler Thromb Vasc Biol, 2005; 25: 2062-2068
35. Ruzickova J, Rossmeisl M, Prazak T, Flachs P, Sponarova J, Veck M, Tvrzicka E, Bryhn M, Kopecky J: Omega-3 PUFA of marine origin limit diet-induced obesity in mice by reducing cellularity of adipose tissue. Lipids, 2004; 39: 1177-1185
36. Kim HK, Della-Fera M, Lin J, Baile CA: Docosahexaenoic acid inhibits adipocyte differentiation and induces apoptosis in 3T3-L1 preadipocytes. J Nutr, 2006; 136: 2965-2969
37. Woodman RJ, Mori TA, Burke V, Puddey IB, Watts GF, Beilin LJ: Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension. Am J Clin Nutr, 2002; 76: 1007-1015
38. Lee MJ, Wu Y, Fried SK: Adipose tissue heterogeneity: implication of depot differences in adipose tissue for obesity complications. Mol Aspects Med, 2013; 34: 1-11
39. Rustan AC, Nossen JO, Christiansen EN, Drevon CA: Eicosapentaenoic acid reduces hepatic synthesis and secretion of triacylglycerol by decreasing the activity of acylcoenzyme A: 1,2-diacylglycerol acyltransferase. J Lipid Res, 1988; 29: 1417-1426
40. Halminski MA, Marsh JB, Harrison EH: Differential effects of fish oil, safflower oil and palm oil on fatty acid oxidation and glycerolipid synthesis in rat liver. J Nutr, 1991; 121: 1554-1561
41. Kim HJ, Takahashi M, Ezaki O: Fish oil feeding decreases mature sterol regulatory element-binding protein 1 (SREBP-1) by down-regulation of SREBP-1c mRNA in mouse liver. A possible mechanism for down-regulation of lipogenic enzyme mRNAs. J Biol Chem, 1999; 274: 25892-25898
42. Nakatani T, Kim HJ, Kaburagi Y, Yasuda K, Ezaki O: A low fish oil inhibits SREBP-1 proteolytic cascade, while a high-fish-oil feeding decreases SREBP-1 mRNA in mice liver: relationship to anti-obesity. J Lipid Res, 2003; 44: 369-379
43. Jump DB: The biochemistry of n-3 polyunsaturated fatty acids. J Biol Chem, 2002; 277: 8755-8758
44. Chujo D, Yagi K, Asano A, Muramoto H, Sakai S, Ohnishi A, Shintaku-Kubota M, Mabuchi H, Yamagishi M, Kobayashi J: Telmisartan treatment decreases visceral fat accumulation and improves serum levels of adiponectin and vascular inflammation markers in Japanese hypertensive patients. Hypertens Res, 2007; 30: 1205-1210
45. Hirasawa A, Tsumaya K, Awaji T, Katsuma S, Adachi T, Yamada M, Sugimoto Y, Miyazaki S, Tsujimoto G: Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nat Med, 2005; 11: 90-94
46. Im DS: Omega-3 fatty acids in anti-inflammation (proresolution) and GPCRs. Prog Lipid Res, 2012; 51: 232-237
47. Ichimura A, Hirasawa A, Poulain-Godefroy O, Bonnefond A, Hara T, Yengo L, Kimura I, Leloire A, Liu N, Iida K, Choquet H, Besnard P, Lecoeur C, Vivequin S, Ayukawa K, Takeuchi M, Ozawa K, Tauber M, Maffeis C, Morandi A, Buzzetti R, Elliott P, Pouta A, Jarvelin MR, Körner A, Kiess W, Pigeyre M, Caiazzo R, Van Hul W, Van Gaal L, Horber F, Balkau B, Lévy-Marchal C, Rouskas K, Kouvatsi A, Hebebrand J, Hinney A, Scherag A, Pattou F, Meyre D, Koshimizu TA, Wolowczuk I, Tsujimoto G, Froguel P: Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human. Nature, 2012; 483: 350-354
48. Waguri T, Goda T, Kasezawa N, Yamakawa-Kobayashi K: The combined effects of genetic variations in the GPR120 gene and dietary fat intake on obesity risk. Biomed Res, 2013; 34: 69-74
49. Ramel A, Martinéz A, Kiely M, Morais G, Bandarra NM, Thorsdottir I: Beneficial effects of long-chain n-3 fatty acids included in an energy-restricted diet on insulin resistance in overweight and obese European young adults. Diabetologia, 2008; 51: 1261-1268
50. Haugaard SB, Madsbad S, Høy CE, Vaag A: Dietary intervention increases n-3 long-chain polyunsaturated fatty acids in skeletal muscle membrane phospholipids of obese subjects. Implications for insulin sensitivity. Clin Endocrinol (Oxf), 2006; 64: 169-178
51. Neschen S, Morino K, Dong J, Wang-Fischer Y, Cline GW, Romanelli AJ, Rossbacher JC, Moore IK, Regittnig W, Munoz DS, Kim JH, Shulman GI: n-3 Fatty acids preserve insulin sensitivity in vivo in a peroxisome proliferator-activated receptor-alpha-dependent manner. Diabetes, 2007; 56: 1034-1041
52. Kadowaki T, Yamauchi T: Adiponectin and adiponectin receptors. Endocr Rev, 2005; 26: 439-451
53. Mostad IL, Bjerve KS, Bjorgaas MR, Lydersen S, Grill V: Effects of n-3 fatty acids in subjects with type 2 diabetes: reduction of insulin sensitivity and time-dependent alteration from carbohydrate to fat oxidation. Am J Clin Nutr, 2006; 84: 540-550